Neoadjuvant Bintrafusp Alfa in Patients With Resectable Biliary Tract Cancer
Status:
Recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
The NEOBIL study aims to investigate the feasibility, safety and efficacy of neoadjuvant
Bintrafusp alfa in patients with resectable biliary tract cancer.